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replacementCarlos A. Mestres, MD, PhD, FETCSAortic stenosis (AS) is a surgical disease, and patients are
best treated with valve replacement at any age and condi-
tion, as it has been well documented over time.1-3 Theresults of the study of transcatheter versus surgical aortic
valve replacement (SAVR) in high-risk patients correspond-
ing to the Placement of Aortic Transcatheter Valves (PART-
NER) trial published in 2011 suggested that in high-risk
patients with severe AS, transcatheter and surgical proce-
dures for AVR were associated with similar survival at 1
year, although there were important differences in peripro-
cedural risks.4 This was despite a number of well-
acknowledged limitations, such as the noninferiority
design, frequent unexpected withdrawals, and lack of statis-
tical power for robust conclusions in specific subgroups of
patients. It is expected that technologic advancement will
improve outcomes if current procedural and postprocedural
limitations are overcome and some indications clearly
defined.5-7 At this time, SAVR and transcatheter valve
implantation are treatment options covering almost all
possible groups of patients requiring an aggressive
treatment of AS; however, there are still some doubts ongery c December 2014
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Dspecific subgroups whose problem is the decision for an
intervention.
In this issue of the Journal, Grupper and colleagues8
aimed at investigating the effect of aortic valve intervention
on survival in the subgroup of patients with low-gradient se-
vere AS and preserved left ventricular function. They also
speculated on the eventual influence of normal or decreased
stroke volume. Their analysis covered a cohort of 416 pre-
dominantly female patients (58%) with a mean age of 76
 14 years. The subgroup of patients with low-flow, low-
gradient AS had higher body surface area and body mass in-
dex, and lower peak velocity, mean gradient, stroke volume,
and ejection fraction. Over an average follow-up of 28
months, 23% of patients (97/416) underwent aortic valve
intervention and 32% of patients (140/416) died. The pre-
dominant intervention was SAVR. The authors concluded
that aortic valve intervention is associated with improved
survival among patients with low-gradient severe AS.
There are some issues of interest in this contribution.
First, it stresses the difficulties of the evaluation and diag-
nosis of patients with AS and low transvalvular gradient
with preserved left ventricular function. There are a number
of technical aspects in the echocardiographic management
that may lead to inappropriate estimates. This contribution
supports the use of gradients as a main parameter for recom-
mending aggressive treatment, although the aortic valve
orifice area, estimation of transvalvular gradients, and
stroke volume index do configure well on aggregate the
conflictive perception of this subgroup of patients analyzed.
The benefit of SAVR is clear across the spectrum of this
population regardless of the aortic valve area and transvalv-
ular ejecting volume. The prognosis of these patients has
greatly improved regardless of specific clinical and echo-
cardiographic parameters. There may still be some concerns
in the specific subpopulation with low-flow AS (113 in this
study) in the long-term, as recently stated byMohty and col-
leagues,9 when the variable patient–prosthesis mismatch
was included; however, this may have an impact on the
long-term and not on acute results, meaning that there
will be benefit in referring these patients for surgery.
Most important is that the authors agree that patients must
undergo operation. This is in agreement with the data shown
in the article.8 It is clear that all patients must be referred for
surgical treatment regardless of the transaortic flow when
AS is present. There are, of course, a number of limitations,
including the study design, the eventual bias with regard toThe Journal of Thoracic and Carthe severity of symptoms at the time of referral for interven-
tion, and the formula used for the calculation of valve area
and ejection fraction. However, as according to Grupper
and colleagues,8 there has been improved survival in both
low- and normal-flow AS with low gradient, intervention
is warranted. The decision for intervention should be based
on prompt recognition of the problem.
A final remark is that these conclusions are drawn by a
group of cardiologists who recognized that patients must
be referred early for surgical treatment of AS, an old story
with updated confirmation. The readers must then be inter-
ested in such a simple conclusion. Despite recent advance-
ments in the current era of transcatheter therapies, SAVR for
AS continues to be one of the best operations ever designed
and performed in all patients at any age with reliable results
on the perioperative period and, most important, over
time.10,11
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